Prudential Financial Inc Precision Biosciences Inc Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.45 $2,668 - $4,140	9,200 Added 12.54%	82,550 $29,000
Q3 2023 Nov 13, 2023	BUY	$0.34 - $0.69 $24,939 - $50,611	73,350 New	73,350 $24,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $169,797 - $493,151	-147,650 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.96 - $7.76 $437,044 - $1.15 Million	147,650 New	147,650 $455,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $172,050 - $271,095	-23,250 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $213,435 - $328,987	23,250 New	23,250 $268,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $550M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.